Influence of enhanced antigenicity of renal vascular endothelium induced ischemia/reperfusion injury on the antigen antibody reaction in organ transplantation and the study of protective strategy for enhancedantigenicity

肾血管内皮抗原性增强所致缺血/再灌注损伤对器官移植抗原抗体反应的影响及增强抗原性保护策略的研究

基本信息

  • 批准号:
    15591668
  • 负责人:
  • 金额:
    $ 1.73万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Several studies suggested that the vascular endothelial cells function as resident antigen presenting cells by presenting not only human leukocyte antigen but also costimulatory adhesionmoleculesB7 and these molecules expression was up-regulated both during acute rejection and after ischemia/reperfusion (I/R) injury. I/R injury may enhance allograft antigenicity in organ transplantation without antigen-antibody reaction. The present research studied the protective effects of resveratrol, a phenolic product anti-oxidant, on renal function and the expression of CD86 in rat kidneys with I/R injury.Wister rats were divided into four groups ; an I/R group, receiving right nephrectomy and 1-hour clamping of the left renalpedicle ; a Vehicle group, I/R plus 10% ethanol (0.1 ml/kg) by intra-peritoneum from day -1 through to 7; a Resveratrol group, I/S plus 4mg/kg resveratrol ; and a Shamgroup. Blood samples were obtained viathetailveinat-1,1,3,and 7days after the operation for the measurement … More of serum creatinine (Scr) levels. The expression of the CD86 protein was examined by immunofluorescence staining and quantitative level of CD86 messenger RNA (mRNA) was by real time reverse transcription polymerase chain reaction in the renal cortex at day 3. The presence of oxidative damage was assessed by determining the level of thiobarbituric acid reactive substance (TBARS) in renal homogenates.Scr levels of the Resveratrol group were significantly lower than those of the I/R and Vehicle groups on days 1 and 3 after the operation. The expression of CD86 protein in the glomerular endothelium was attenuated in the Resveratrol group compared to the I/R or Vehicle group. In the Resveratrol group, the CD86 mRNA levels was significantly lower than that in the I/R or Vehicle group, moreover, it was significantly lowerly about one fifth than that in the Shamgroup.Our results suggested that resveratrol markedly reduces renaldys function and at tenuates the mRNA and protein expression of CD86 following I/R injury. Less
研究表明,血管内皮细胞作为常驻抗原提呈细胞,不仅提呈人类白细胞抗原,而且还提呈共刺激粘附分子B7,在急性排斥反应和缺血/再灌注(I/R)损伤后,这些分子的表达均上调。在无抗原抗体反应的器官移植中,I/R损伤可增强同种异体抗原性。本研究旨在探讨酚类抗氧化剂白藜芦醇(resveratrol)对大鼠肾I/R损伤后肾功能的保护作用及其对CD 86表达的影响。a媒介物组,I/R加10%乙醇(0.1ml/kg),从第-1天到第7天腹膜内; a白藜芦醇组,I/S加4 mg/kg白藜芦醇;和a假手术组。分别于术后1、1、3、7天经尾静脉采血测定 ...更多信息 血清肌酐(Scr)水平。免疫荧光染色检测肾皮质CD 86蛋白的表达,真实的时间反转录聚合酶链反应检测肾皮质CD 86 mRNA的表达。通过测定肾匀浆中硫代巴比妥酸反应物质(TBARS)的水平来评估氧化损伤的存在。白藜芦醇组的Scr水平在术后第1天和第3天显著低于I/R组和溶媒组。与I/R或Vehicle组相比,白藜芦醇组中肾小球内皮中的CD 86蛋白表达减弱。白藜芦醇组CD 86 mRNA表达水平明显低于I/R组和Vehicle组,且较Sham组低约1/5,提示白藜芦醇可明显降低I/R损伤后肾功能,并抑制CD 86 mRNA和蛋白表达。少

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneys with ischemia/reperfusion injury.
酚类化合物白藜芦醇对缺血/再灌注损伤大鼠肾脏肾功能和共刺激粘附分子 CD86 表达的影响。
  • DOI:
    10.1679/aohc.68.41
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Saito*;S. Satoh;N. Kojima;H. Tada;Mitsuru Sato;Toshio Suzuki;H. Senoo;T. Habuchi
  • 通讯作者:
    T. Habuchi
Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidney with ischemia/reperfusion injury
酚类化合物白藜芦醇对缺血/再灌注损伤大鼠肾脏肾功能及共刺激粘附分子CD86表达的影响
Effects of phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneu with ischemia/reperfusion iniury
酚类化合物白藜芦醇对缺血/再灌注损伤大鼠肾功能及共刺激粘附分子CD86表达的影响
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SATOH Shigeru其他文献

THE MUTUAL RELATIONSHIP BETWEEN ESTABLISHED PROCESS OF RECONSTRUCTION GOVERNANCE AND IMPLEMENTED PROCESS OF RECONSTRUCTION PROJECT
重建治理制定过程与重建项目实施过程之间的相互关系

SATOH Shigeru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SATOH Shigeru', 18)}}的其他基金

Analysis of the role of abscisic acid in the induction of ethylene biosynthesis in cut carnation flowers undergoing senescence
脱落酸诱导衰老康乃馨切花乙烯生物合成的作用分析
  • 批准号:
    24580050
  • 财政年份:
    2012
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Community management for citizen participation and self-governing improvement in China
中国公民参与和自治的社区管理
  • 批准号:
    23404025
  • 财政年份:
    2011
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Factors Increasing Interstitial Fibrosis and Its Reduction with Personalized Dosing of Immunosuppressive Drugs after Kidney Transplantation
肾移植后增加间质纤维化的因素及其通过个体化剂量免疫抑制药物的减少
  • 批准号:
    23592378
  • 财政年份:
    2011
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical and Genomic Risk Factors for Early Onset of Chronic Allograft Nephropathy
慢性同种异体移植肾病早期发病的临床和基因组危险因素
  • 批准号:
    20591894
  • 财政年份:
    2008
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on community planning for area renovation based on "community" in China.
我国基于“社区”的区域更新社区规划研究
  • 批准号:
    20404019
  • 财政年份:
    2008
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of ethylene-induced senescence in carnation flowers
乙烯诱导康乃馨花衰老的分子机制
  • 批准号:
    19380024
  • 财政年份:
    2007
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of total supporting system with interactive simulation system for pre-recovering for anti-desaster
抗灾预恢复交互式模拟系统整体支撑系统开发
  • 批准号:
    14205089
  • 财政年份:
    2002
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of molecular mechanism of long-lasting carnations
康乃馨长寿的分子机制分析
  • 批准号:
    14360013
  • 财政年份:
    2002
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Preservation of cut carnation flowers by the use of chemicals without environmental toxicity
使用无环境毒性的化学品保存康乃馨切花
  • 批准号:
    07556009
  • 财政年份:
    1995
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Urban Pedevelopment of Civic Districts in Japan Castle-Towns in Nineteen Century
19世纪日本城下町市区的城市化发展
  • 批准号:
    07455247
  • 财政年份:
    1995
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
  • 批准号:
    82371142
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
  • 批准号:
    81070041
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
  • 批准号:
    23K21458
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a customed designed oxygenation system combined with novel therapy to treat reperfusion injury following Neurovascular Thrombectomy.
开发定制设计的氧合系统与新疗法相结合,治疗神经血管血栓切除术后的再灌注损伤。
  • 批准号:
    10057485
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Collaborative R&D
Mitochondrial Calcium and Neuronal Health
线粒体钙和神经元健康
  • 批准号:
    10638869
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Nanowired humam cardiac organoid derived exosomes for heart repair
纳米线人类心脏类器官衍生的外泌体用于心脏修复
  • 批准号:
    10639040
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
  • 批准号:
    10677394
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Biology the initiator: Harnessing Reactive Oxygen Species for Biocompatible Polymerization
生物学引发者:利用活性氧进行生物相容性聚合
  • 批准号:
    10667740
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
High subzero preservation of liver for transplantation
移植用肝脏的高度低温保存
  • 批准号:
    10815970
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Regulation of CSE-Derived Hydrogen Sulfide in the Heart
CSE 衍生的硫化氢在心脏中的调节
  • 批准号:
    10659832
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease
血红素介导的线粒体损伤、衰老、急性肾损伤和慢性肾病
  • 批准号:
    10656648
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
Low-Dose Magneto-Thrombolysis to Expand Stroke Care
低剂量磁溶栓扩大中风治疗范围
  • 批准号:
    10693650
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了